An Open-Label Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in Study MYK-461-004 (PIONEER)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 11 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

31 Jan 2024 Status changed from active, no longer recruiting to completed.
06 Mar 2023 Updated Results for cardiac hemodynamics and biomarkers, symptoms and quality of life, presented at the 72nd Annual Scientific Session of the American College of Cardiology together with the World Heart Federation
27 Feb 2023 According to a Bristol-Myers Squibb media release, data from the study will be presented at the American College of Cardiology Annual Scientific Session Together With World Congress of Cardiology.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com